Tyra Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	73.84	77.39	91.97	58.01	251.21	302.18
Short-Term Investments	280.11	178.62	249.48	145.46	-	-
Cash & Short-Term Investments	353.94	256	341.44	203.47	251.21	302.18
Cash Growth	19.47%	-25.02%	67.81%	-19.00%	-16.87%	1884.90%
Other Current Assets	13.02	9.45	6.02	8.2	6.08	1.88
Total Current Assets	366.97	265.45	347.46	211.67	257.29	304.06
Net Property, Plant & Equipment	6.48	6.89	7.72	8.15	3.54	2.09
Other Long-Term Assets	9.91	10.27	8.38	6.03	5.35	0.56
Total Assets	383.36	282.61	363.56	225.86	266.18	306.7
Accounts Payable	2.33	1.18	0.59	4.66	1.15	0.6
Accrued Expenses	21.78	16.44	13.59	10.39	4.42	2.82
Current Portion of Leases	0.5	0.47	0.41	0.28	0.14	0.2
Total Current Liabilities	24.62	18.09	14.59	15.33	5.7	3.62
Long-Term Leases	5.08	5.34	5.81	6.22	2.48	0.98
Other Long-Term Liabilities	-	-	0	0.05	0.17	0.37
Total Long-Term Liabilities	5.08	5.34	5.81	6.26	2.65	1.35
Total Liabilities	29.7	23.43	20.41	21.6	8.35	4.96
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	810.36	630.04	593.69	368.71	353.52	342.1
Accumulated Other Comprehensive Income	-0.58	0.39	0.77	0.38	-	-
Retained Earnings	-	-371.26	-251.31	-164.83	-95.7	-40.37
Total Common Shareholders' Equity	353.66	259.18	343.15	204.26	257.83	301.74
Shareholders' Equity	353.66	259.18	343.15	204.26	257.83	301.74
Total Liabilities & Equity	383.36	282.61	363.56	225.86	266.18	306.7
Total Debt	5.58	5.81	6.22	6.5	2.62	1.18
Net Cash (Debt)	348.36	250.19	335.22	196.97	248.59	301
Net Cash Growth	20.02%	-25.36%	70.19%	-20.76%	-17.41%	1895.75%
Net Cash Per Share	5.64	4.20	5.86	4.61	5.93	21.84
Book Value	353.66	259.18	343.15	204.26	257.83	301.74
Book Value Per Share	5.72	4.35	6.00	4.78	6.16	21.90
Tangible Book Value	353.66	259.18	343.15	204.26	257.83	301.74
Tangible Book Value Per Share	5.72	4.35	6.00	4.78	6.16	21.90

SEC Filings: 10-K · 10-Q